# talks
Collection of slide sets 

## 2021

* R/Pharma 2021: Risk-based Assessment of R Packages at Merck KGaA/ EMD Serono, Nov 2-4, 2021
* rOpenSci Community Call: Expanding Software Peer Review: Statistical Package Standards at rOpenSci (On behalf of the R validation hub): https://ropensci.org/commcalls/oct2021-statsreview02/
* ASA BIOP 2021. Estimands for Overall Survival with Treatment Switching, September 21-24, 2021.
* SCT 2021. How the estimand addendum to the ICH E9 guideline helps structure clinical objectives, analyses, and conclusions. May 17-21, 2021. 

## 2020

* GMDS & CEN-IBS 2020. Estimands for Overall Survival with Treatment Switching September 6-11, 2020.
* useR! 2020 A risk-based Assessment for R Package Accuracy. On behalf of the R validation hub.
* Immuno-Oncology 360Â°. Association between response assessment using RECIST and irRECIST in 1765 patients with advanced solid tumors treated with avelumab monotherapy February 26-28, 2020. New York City, NY, USA.

## 2019

* R/Pharma 2019. Optimize Installation Routines for R Package Dependencies. August 21-23, 2019.
* R Ladies Boston. Introduction to Building R Packages. January 30, 2019.

## 2018

* R/Pharma 2018. Multi-state Model for the Analysis of an Association between Safety and Efficacy Events Using R. August 15-16, 2018, Cambridge, MA USA.
* 64th Biometrical Colloquium: Multi-state Model for the Analysis of an Association between Safety and Efficacy Events. March 26, 2018, Frankfurt, Germany.


